Similar CAR T expansion dynamics have been observed for CD19-targeting CAR T-cell agents in diffuse large B-cell lymphoma (DLBCL) and B-acute lymphoblastic leukemia (B-ALL) studies [26–29]. This evidence concerns the gene CD19 and precursor B-cell acute lymphoblastic leukemia.